Corona Remedies, the Ahmedabad-headquartered mid-sized pharmaceutical firm, has acquired two diabetes and hyperthyroidism brands, Obimet and Thyrocab, comprising 14 product line extensions, from...
Abbott wins U.S. antitrust approval to buy Alere with conditions
Abbott Laboratories has won U.S. antitrust approval to buy Alere Inc on condition that it sell two point-of-care medical testing businesses, the Federal Trade Commission said on Thursday. Canada also announced on...
Abbott agrees to buy Alere at lower price from earlier offer
Diversified healthcare company Abbott Laboratories (ABT.N) on Friday agreed to buy Alere Inc (ALR.N) at a lower price than it had previously offered, after raising concerns about the accuracy of various representations...
Abbott gets U.S. antitrust approval to buy St. Jude Medical
Healthcare company Abbott Laboratories (ABT.N) has won U.S. antitrust approval for its proposed $25 billion acquisition of medical device maker St. Jude Medical Inc (STJ.N), the U.S. Federal Trade Commission said on...
U.S. regulator poised to approve Abbott purchase of St Jude – sources
U.S. antitrust enforcers are poised to approve health care company Abbott Laboratories’ (ABT.N) purchase of medical device maker St. Jude Medical Inc (STJ.N), two sources knowledgeable about the deal said on...
CCI clears Abbott-St Jude deal subject to ‘voluntary remedies’
NEW DELHI: Competition Commission has approved pharma major Abbott Laboratories’ proposed acquisition of heart device maker St Jude Medical Inc, subject to certain “voluntary remedies”. Both the...
Abbott Files Suit to Terminate $5.8 Billion Alere Purchase
Abbott Laboratories filed suit to terminate its $5.8 billion purchase of Alere Inc., citing setbacks since the deal was signed in January that it says have significantly eroded the value of the medical-test maker. The...
EU regulator conditionally approves Abbott’s purchase of St Jude
The European Commission on Wednesday said it has given its conditional approval to U.S. medical device maker Abbott Laboratories’ (ABT.N) bid for peer St Jude Medical Inc (STJ.N). Reuters reported on Nov. 15 that...
EU regulators seen clearing $25 billion Abbott, St Jude deal: source
EU antitrust regulators are expected to give conditional clearance to U.S. medical device maker Abbott Laboratories’ (ABT.N) $25 billion bid for rival St. Jude Medical Inc (STJ.N), a person familiar with the...
Abbott offers EU concessions over $25 billion St. Jude deal
Medical device maker Abbott Laboratories (ABT.N) has offered concessions in an attempt to secure EU antitrust approval for its $25 billion bid for St Jude Medical Inc (STJ.N), according to the European Commission. The...
St. Jude, Abbott Sell Products to Terumo for $1.12 Billion
Abbott Laboratories and St. Jude Medical Inc. will divest some of their cardiovascular products to Terumo Corp. for $1.12 billion in order to complete the $25 billion deal between the two medical device giants. The all...
Abbott to buy Wockhardt’s nutrition biz for $130 m
Pharmaceutical and biotechnology major Wockhardt will sell its nutrition business to global healthcare company Abbott. While Wockhardt did not disclose the financial details, a Chicago Tribune report said the deal was...